Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoradiotherapy followed by surgery for Pancoast tumors
NCT00128037Phase 2Completed
- Sponsor
- Japan Clinical Oncology Group
- Start
- May 1999
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mitomycin c, vindesine and cisplatin in Pancoast tumor, sponsored by Japan Clinical Oncology Group. Primary endpoint: 3-year Overall Survival Rate. Started May 1999; status: completed.
02
Drugs
mitomycin cvindesinecisplatin
03
Conditions
Pancoast tumor
Beyond the preview
Go deeper on NCT00128037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128037.